Authors
Latest:
Increased Health Care Provider Education Needed to Reduce Opioid Prescribing for Juvenile FibromyalgiaThe findings demonstrated that female gender, older age, and Caucasian race were the most likely predictors of opioid use in patients with JFMS.
Latest:
Prevent Potential Liability to State and Federal Agencies for "Excluded Providers"Health care and pharmacy practices must regularly verify that their employees are not excluded from participation in Medicare, Medicaid, or other federal health programs.
Latest:
Economic Outcomes of Warfarin Discontinuation Among Patients with Atrial FibrillationThis study seeks to determine the economic effects of warfarin discontinuation in patients with nonvalvular atrial fibrillation.
Latest:
Reducing 30-day Readmission Rates Through Compliance Calls Post-DischargeThe discharge pharmacy service at West Virginia University (WVU) Medicine in Morgantown is intended to be a ‘patient first’ program that ensures patients receive the medications prescribed in hand, and that they remain adherent through medication counseling and followup.
Latest:
Economic Model of Granulocyte Colony-Stimulating Factors for Patients Receiving ChemotherapyFor US payers, pegfilgrastim is a less-expensive choice than daily filgrastim for reducing the risk of febrile neutropenia in patients receiving myelosuppressive chemotherapy.
Latest:
The Expanding Roles of Genetic Counselors in Specialty Pharmacy ManagementCurrently, genetic counselors apply their molecular and clinical expertise in diverse roles, many delivered via telehealth.
Latest:
Outpatient Cancer Center Cost Evaluation of Extended Beyond-Use Dating with a Closed-System Transfer DeviceThere is a constant balancing act for health care systems to provide the newest and most up-to-date care for patients while being financially responsible.
Latest:
National Comprehensive Cancer Network Issues Guidance on COVID-19 Vaccination for Patients With CancerNCCN states that all patients with active cancer, or with active, recent, or planned cancer treatment, should be considered highest priority to receive one of the COVID-19 vaccines granted emergency use authorization.
Latest:
An Exciting Future for the Scope of Pharmacy PracticeWho would have thought that the girl who could not even swallow a pill at the age of 14 would pursue a career as a pharmacist?
Latest:
An Indian Perspective on OpioidsTo the dismay of many health care professionals, opioid abuse has become an epidemic in the United States.
Latest:
Administration Costs of Denosumab and Zoledronic Acid for Postmenopausal OsteoporosisThis is the first study to report, in detail, patterns of resource use and costs associated with real-world administration of denosumab and zoledronic acid.
Latest:
Working with Pharmacy Employees: Mistakes to AvoidAn overview of the most common human resources problems that pharmacies face and the proactive steps that pharmacies can take to avoid these problems.
Latest:
Incentive Formularies: Spending and Utilization for 3 Common Drug ClassesIncentive formularies with varying cost sharing led to modestly lower overall spending, with savings for plan sponsors offset by increased out-of-pocket spending.
Latest:
Insulin Pump Therapy and Continuous Glucose MonitoringInsulin pump therapy and continuous glucose monitoring systems can be invaluable tools for patients with type 1 and type 2 diabetes.
Latest:
Analyzing the Impact of Different Value-Based Insurance Design ProgramsTotal 1-year healthcare costs were not significantly reduced by 2 value-based insurance design programs for diabetic patients, although education appeared to improve quality of care.
Latest:
Impact of Initial Days' Supply of Angiotensin II Receptor BlockersFor ARB-class antihypertensive agents, we examined the association among initial prescription supply days (ie, 30- or 90-day) and adherence, hospitalization risk, and healthcare use.
Latest:
Uncovering Hidden Savings in the Hospital PharmacyThe shift from fee-based, volume-driven care to value-based, patient-centered care and the growth of specialty pharmaceuticals are propelling us all into uncharted territory, no matter what role you play in health care.
Latest:
Effectiveness and Costs of Biologics in Veterans With Rheumatoid ArthritisThis study applied a validated algorithm to estimate the effectiveness and costs of the index biologic used by 4696 US veterans with rheumatoid arthritis.
Latest:
Overactive Bladder Disease: Overcoming the Urge to GoWhen discussing overactive bladder disease with a patient, the pharmacist needs to be sensitive to this treatable but often embarrassing medical condition.
Latest:
Effectiveness and Costs of Biologics in Veterans With Rheumatoid ArthritisThis study applied a validated algorithm to estimate the effectiveness and costs of the index biologic used by 4696 US veterans with rheumatoid arthritis.
Latest:
Offer Patients Counseling on ADFsPharmacists can extend education to prescribers and provide important guidance on abuse-deterrent opioid formulations.
Latest:
Natural Products on Deck: Keeping Joints in the GameMany patients with osteoarthritis turn to complementary and alternative medicine, either as an adjunct to prescription therapy or to avoid side effects.
Latest:
Parkinson's Disease Psychosis: A Pharmacist's Update of New Treatment OptionsThis Continuing Education activity is supported by an educational grant from Acadia Pharmaceuticals Inc.
Latest:
Opioid-Induced Constipation: Considerations for Formulary Decision MakersThis activity reviews the incidence and impact of opioid-induced constipation (OIC), discusses available treatment options, and what factors should be considered during formulary decisions for OIC.
Latest:
Drivers of Change in Pharmacy Benefit ManagementExecutive-level pharmacy leaders in US managed care organizations identify how healthcare reform is driving changes in pharmacy benefit management.
Latest:
Ivosidenib for Relapsed/Refractory Acute Myeloid LeukemiaOn July 20, 2018, the FDA approved ivosidenib (Tibsovo) as a treatment option for adult patients with relapsed/refractory acute myeloid leukemia, specifically with a mutation in the IDH1 gene.
